Why Moderna Might Be a One-Hit Wonder
Can you believe that Moderna (NASDAQ: MRNA) was once worth more than $195 billion in 2021? Back then, the business looked on track to be the next big healthcare company.
Then, demand for its COVID-19 vaccine started to diminish. As hospitals resumed normal operations and anti-vaccine sentiment grew, there wasn't nearly as much demand for COVID-19 shots anymore. While Moderna still generates revenue from its vaccine, it's just a fraction of what it was in 2021.
Image source: Getty Images.
Source Fool.com
Moderna Inc. Stock
€39.29
-0.640%
Based on 7 Buy predictions and 9 Sell predictions the sentiment towards Moderna Inc. is rather balanced.
A potential of -46.55%, resulting from comparing the current price of 39.29 € with the target price of 21 € for Moderna Inc., shows the chance of incurring significant losses.
